Validation of the Edmonton‐33: A Patient‐Reported Outcome Instrument in Head and Neck Oncology at Baseline and Subacute Phases Post‐Treatment
The E-33 demonstrates validity pre-treatment and post-treatment at subacute timepoint (Months 6) for capturing data on swallowing, chewing, dry mouth, and speech, similar to other previously validated instruments. This validity is limited at the more acute timepoint of 3 months post-treatment and the later timepoint of 9 months post-treatment. Additional data are needed to further explore the long-term validity at further longitudinal timepoints at 1 and 2 years post-treatment.
Authors
- S. Danielle MacNeil (ORCID: https://orcid.org/0000-0001-6666-9055)
- Anthony C. Nichols (ORCID: https://orcid.org/0000-0002-0760-980X)
- Hafiz Khan (ORCID: https://orcid.org/0000-0002-4324-7842)
- Katherynn Zhang (ORCID: https://orcid.org/0000-0002-6134-4574)
- Adrian Mendez (ORCID: https://orcid.org/0000-0002-9202-5875)
- Hadi Seikaly (ORCID: https://orcid.org/0000-0002-8939-1364)
- K. Fung
Institutions
- Western University (CA)
- University of Alberta (CA)
- London Health Sciences Centre (CA)
Publication Details
- Journal
- Journal of Oral Pathology and Medicine
- Published
- 2025-05-02
- DOI
- https://doi.org/10.1111/jop.13640
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00